These compounds may interact with:
Hormone-sensitive lipase
Potentially involved in: familial partial lipodystrophy; diabetes mellitus; obesity; carcinoma; lipid metabolism disorder; multiple symmetric lipomatosis; acanthosis nigricans; hepatomegaly; insulin resistance; lipodystrophy; oligomenorrhea; polycystic ovary syndrome; elevated creatine kinase; creatine phosphokinase serum increased; dyslipidemias; obesity, abdominal; insulin resistant diabetes; sclerocystic ovaries; hypertriglyceridemia result; increased intraabdominal fat
Disease data sourced from Pharos.